Cardiovascular diseases are associated with and/or caused by oxidative stress. This concept has been proven by using the approach of genetic deletion of reactive species producing (pro-oxidant) enzymes as well as by the overexpression of reactive species detoxifying (antioxidant) enzymes leading to a marked reduction of reactive oxygen and nitrogen species (RONS) and in parallel to an amelioration of the severity of diseases. Likewise, the development and progression of cardiovascular diseases is aggravated by overexpression of RONS producing enzymes as well as deletion of antioxidant RONS detoxifying enzymes. Thus, the consequences of the interaction (redox crosstalk) of superoxide/hydrogen peroxide produced by mitochondria with other ROS producing enzymes such as NADPH oxidases (Nox) are of outstanding importance and will be discussed including the consequences for endothelial nitric oxide synthase (eNOS) uncoupling as well as the redox regulation of the vascular function/tone in general (soluble guanylyl cyclase, endothelin-1, prostanoid synthesis). Pathways and potential mechanisms leading to this crosstalk will be analysed in detail and highlighted by selected examples from the current literature including hypoxia, angiotensin II-induced hypertension, nitrate tolerance, aging and others. The general concept of redox-based activation of RONS sources via "kindling radicals" and enzyme-specific "redox switches" will be discussed providing evidence that mitochondria represent key players and amplifiers of the burden of oxidative stress.
LINKED ARTICLESThis article is part of a themed section on Redox Biology and Oxidative Stress in Health and Disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.12/issuetoc Abbreviations ΔΨ m , mitochondrial membrane potential; 5-HD, 5-hydroxydecanoic acid; ADMA, asymmetric dimethylarginine; AT-II, angiotensin-II; BH 4 , tetrahydrobiopterin; cGMP, cyclic guanosine monophosphate; COX, cyclooxygenase; eNOS, endothelial nitric oxide synthase; ET-1, endothelin-1; GCH-1, GTP cyclohydrolase-1; K ATP ,, ATP-sensitive potassium channel; MAO, monoamine oxidase (isoforms A and B); MAPK, mitogen-activated protein kinases; MitoSOX, triphenylphosphonium dihydroethidium (mitochondria-targeted superoxide probe); MitoQ, triphenylphosphonium quinone (mitochondria-targeted antioxidant); MnSOD, manganese superoxide dismutase; mPTP, mitochondrial permeability transition pore; mtK ATP ,, mitochondrial K ATP ; mtROS, mitochondrial reactive oxygen species; nNOS, neuronal nitric oxide synthase; Nox, NADPH oxidase catalytic subunit (isoforms 1, 2 and 4); PGIS, prostacyclin; PKC, protein kinase C; RNS, reactive nitrogen species (accounts in the present review mostly for peroxynitrite and nitrogen dioxide); ROS, reactive oxygen species (accounts in the present review mostly for superoxide and hydrogen peroxide); sGC, soluble guanylyl cyclase; SOD, superoxide dismutase; Src (or cSrc), tyrosine kinase; XDH, xanthine dehydrogenase; XO, xanthine oxidase...